Digital health funding in Clinical Trials: Why Execution, Not Discovery, is Pharma’s Next Existential Bottleneck
TL;DR The Bottleneck Has Shifted: TechBio funding surged +75%. Clinical trial funding fell -30%. Trials still consume >50% of total R&D costs.…
